Stimulant Addiction

What Are Stimulants?

Stimulants increase nervous-system activity and can promote wakefulness or affect the heart and body temperature.^[1][2] Important stimulant groups include prescription psychostimulants (medicines with stimulating effects on the brain) and illicit stimulants such as cocaine and methamphetamine. Understanding their differences helps separate treatment evidence from illicit-use risks.^[3][4]

When Stimulant Effects Need Emergency Help

Call 911 for a suspected overdose or severe stimulant effects such as chest pain, seizure, high fever, or psychosis. Psychosis can include hallucinations or severe paranoia. These symptoms need emergency assessment.^[5][4]

If opioid exposure is possible and the person is unresponsive or breathing abnormally, give naloxone or nalmefene if available while emergency help is coming. These medicines reverse opioid effects, including fentanyl effects, but do not reverse stimulant toxicity.^[8][7]

How Do Different Stimulants Compare?

“Stimulant” describes an effect, not a single chemical family. Different substances act through different pathways, last for different lengths of time, and carry different risks. Dose, formulation, the product’s form, and route of use, how it is taken, such as swallowing, smoking or injecting, matter, as do health conditions and other substances.^[1][4][5]

Two terms help explain the comparison below. Reuptake is the return of a chemical messenger, such as dopamine, into nerve cells after release. Blocking it leaves more messenger available between cells. Half-life is the time it takes the drug level in the body to fall by half; it helps explain duration but is not an exact countdown to when effects end.^[1][5]

For more about other stimulant substances, see our guides to caffeine and nicotine.^[2][11]

Prescription Stimulant Use and Nonmedical Use

For prescribed treatment, useful questions are: What condition is being treated? What benefit should we look for? What side effects would make us reconsider treatment? Studies of oral ADHD medicines assessed both symptom improvement and whether side effects led participants to stop treatment.^[3]

When discussing possible nonmedical use (use outside prescribed care) tell the clinician whether the medicine was prescribed for you and whether the amount or route differed from the directions. Assessment of stimulant misuse considers the preparation, amount, frequency, route and other substances used.^[5] Pills from an unverified source may imitate prescription medicines while containing fentanyl.^[8]

Street methamphetamine may appear as powder, crystals, liquid, or pills that imitate prescription products. Its route of use can affect how quickly effects appear, while its relatively long half-life can prolong stimulation.^[4]

How Stimulants Affect the Brain and Body

Stimulants influence neurotransmitters, chemical messengers that nerve cells use to communicate. Norepinephrine, dopamine and serotonin are examples of these messengers; their signaling pathways contribute to stimulants’ effects on the brain, cardiovascular system (the heart and blood vessels) and body temperature. Different stimulants can increase messenger release, block reuptake or do both; they do not all act in the same way.^[1]

Cocaine blocks dopamine reuptake. Methamphetamine both increases dopamine release and blocks its reuptake, producing higher dopamine concentrations. Its longer half-life also contributes to more prolonged effects than cocaine’s.^[5]

How Stimulants Affect Attention and Alertness

In people with ADHD, appropriately selected medications can reduce core symptoms over the short term. The cited trials evaluated treatment of ADHD symptoms; they do not show that feeling energized diagnoses ADHD or that stimulants improve everyone’s judgment, learning or performance.^[3]

Some prescription and non-stimulant wake-promoting medicines are also used for disorders involving severe daytime sleepiness. Their role depends on the diagnosed sleep disorder rather than tiredness alone.^[12]

Stimulant Effects on Reward and Repeated Use

Changes in dopamine signaling are part of stimulant pharmacology, but they do not by themselves establish addiction. Clinicians assess experiences such as craving (a strong desire to use), difficulty controlling use, missed responsibilities and continued use despite harm. These distinguish a problematic pattern from exposure alone.^[5][4]

Treatment can use rewards to encourage recovery-related behaviors. Contingency management provides positive reinforcement, such as tangible incentives, for meeting agreed goals. One example is verified abstinence, meaning not using the substance during the period being assessed.^[7][5]

How Stimulants Affect Sleep and Mood

Methamphetamine’s 10-to-12-hour half-life contributes to effects that last longer than cocaine’s. Insomnia (difficulty sleeping) is among the symptoms commonly observed during ongoing stimulant use and withdrawal, the period of symptoms following a reduction or stopping of use.^[5]

Depression, anxiety and attention problems are also commonly observed during ongoing stimulant use and withdrawal. These symptoms often improve with withdrawal management, but severe or persistent symptoms may need treatment even when they are considered stimulant-related.^[5]

Stimulant Effects on the Heart and Body Temperature

Stimulants can affect the cardiovascular system (the heart and blood vessels) as well as other organs. Complications can involve reduced blood flow, excessive stimulation of the brain and nerves elsewhere in the body, and direct toxic injury to organs.^[1][4]

Some stimulants can also disrupt temperature regulation. MDMA-like drugs may cause life-threatening hyperthermia, meaning dangerously high body temperature. The pharmacology review specifically warns about this risk in rave or club settings.^[1]

Prescribed Stimulants and Addiction Concerns

Prescription stimulants treat conditions including ADHD and some sleep disorders. Taking a prescribed medicine is not, by itself, addiction. If you are worried about dose changes, running out early, or withdrawal, describe those concerns to the prescriber rather than assuming what they mean.^[13][12][5]

How Common Are Stimulant Use, Misuse, and Use Disorder?

Use, misuse and a disorder are different measurements. Using cocaine or methamphetamine does not by itself establish a use disorder; diagnosis considers a pattern of symptoms and consequences. Likewise, national estimates of prescription-stimulant use disorder should not be interpreted as showing that prescribed treatment itself is addiction.^[4][9]

U.S. Stimulant Use and Use Disorder Estimates for 2025

The 2025 National Survey on Drug Use and Health estimated the following among people aged 12 or older:

• In 2025, about 4.9 million people aged 12 or older, or 1.7%, used cocaine in the past year.^[6]
• In 2025, about 2.7 million people aged 12 or older, or 0.9%, used methamphetamine in the past year.^[6]
• In 2025, about 3.9 million people aged 12 or older, or 1.4%, misused prescription stimulants in the past year.^[6]
• In 2025, about 9.5 million people aged 12 or older, or 3.3%, reported past-year misuse of central nervous system stimulants, a broader measure that combines multiple stimulant categories.^[6]

Among people aged 12 or older in 2025, the same survey estimated that 1.4 million people had past-year cocaine use disorder, 1.8 million had methamphetamine use disorder, and 1.7 million had prescription-stimulant use disorder.^[9] Its broader central-nervous-system-stimulant category included an estimated 4.5 million people with a past-year disorder.^[9]

These estimates should not be combined into simple “chance of addiction” calculations. Survey categories, eligibility for diagnostic questions, and denominators differ, and the tables report population-level measurements rather than an individual prognosis.

U.S. Overdose Deaths Involving Stimulants

Stimulant-involved overdose death rates rose between 2018 and 2023. Cocaine-involved deaths increased from 4.5 to 8.6 per 100,000 people, while deaths involving psychostimulants with abuse potential (primarily methamphetamine) increased from 3.9 to 10.4 per 100,000.^[7]

The number of deaths involving cocaine rose from 4,681 in 2011 to 29,449 in 2023.^[7] Deaths involving psychostimulants with abuse potential rose from 2,266 to 34,855 over the same period.^[7] Provisional data showed declines in 2024, but levels remained well above those in 2011.^[7]

“Involving” means a stimulant was considered to have caused or contributed to the death. It does not mean the stimulant acted alone.

In that CDC surveillance sample of 309,274 deaths across 49 states and the District of Columbia, 43.1% involved both stimulants and opioids and 15.9% involved stimulants without opioids.^[7] Thus, about 73% of stimulant-involved deaths also involved an opioid.^[7]

Combining stimulants and opioids matters because opioid reversal medicines do not reverse stimulant effects, and additional treatment for stimulant effects (such as agitation, seizures, or overheating) may be needed.^[7]

Deaths without opioid involvement also require attention. People who died in this group were more likely to be at least 45 years old and to have a known cardiovascular disease history than those whose deaths involved both stimulants and opioids. These are associations from death investigations, not proof that age or prior cardiovascular disease caused an individual death.^[7]

The surveillance findings have limitations. Toxicology practices (testing for substances in the body) vary, emerging stimulants are not routinely tested everywhere, circumstance reports can be incomplete, and some large states were excluded from parts of the analysis.^[7]

How Do Stimulant Dependence, Withdrawal, and Addiction Differ?

These terms describe different experiences. Keeping them separate can reduce stigma and make it easier to recognize when help is needed.

What Stimulant Tolerance Means

Tolerance means that repeated use can reduce a drug’s effect, so a higher amount may be needed for the same effect. The Vyvanse label describes this possibility for a prescription stimulant. Tolerance alone is different from the impaired control and harmful pattern assessed in stimulant use disorder.^[14][5]

Physical Dependence and Stimulant Assessment

Physical dependence means the body has adapted to repeated exposure, so a significant dose reduction or stopping can produce withdrawal symptoms. The Vyvanse label notes that dependence can develop even when the medicine is taken as directed. A clinician assesses withdrawal and the broader pattern of use separately.^[14][5]

Dependence and addiction describe different concepts. Bodily adaptation is not the same as impaired control or continued use despite harm. For stimulant use disorder, assessment looks beyond adaptation to symptoms and their effects on daily functioning.^[8][4]

What Stimulant Withdrawal Can Involve

Stimulant withdrawal can involve depression, anxiety, sleep disturbance, attention problems, and other changes after use stops or decreases. Treatment decisions take account of how severe symptoms are and how long they persist.^[5]

Seek professional assessment for severe or persistent mood or psychotic symptoms, such as hallucinations, seeing or hearing things that are not there. These symptoms may need treatment even when stimulant use or withdrawal contributes to them.^[5][4] For suicidal thoughts or emotional crisis, call or text 988 for 24-hour support.^[15]

Compulsive Use and Stimulant Use Disorder

Compulsive use describes difficulty controlling use even when a person wants to reduce it or is experiencing harm. Stimulant use disorder is a clinical diagnosis based on a broader pattern of symptoms and functional consequences.

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, a diagnostic reference used by clinicians, lists 11 criteria for stimulant use disorder. Examples include craving, repeated failure to meet major responsibilities, unsuccessful efforts to control use, and continued use despite physical or psychological problems.^[4]

A clinician assesses how many criteria occurred within 12 months:

• Mild disorder means two or three criteria.
• Moderate disorder means four or five criteria.
• Severe disorder means six or more criteria.^[4]

A positive drug test alone does not diagnose stimulant use disorder. A test may reflect exposure days earlier and can produce false-positive or false-negative results, incorrectly indicating that a substance is present or absent. It does not explain whether use has caused impaired control or functional harm.^[5]

A meaningful assessment considers frequency and amount, route of use, use with other substances, emergency visits or hospitalizations, overdose history, physical and mental health effects, and whether use is affecting work, school, or home responsibilities.^[5][4]

What Are the Immediate and Longer-Term Risks of Stimulants?

Risk varies substantially by substance, amount, route, pattern, underlying health and co-use. Evidence from illicit exposure should not automatically be applied to a stable prescribed dose.^[4][5]

Acute Stimulant Toxicity

Acute intoxication can become life-threatening and may involve cardiovascular events, psychosis, severe agitation, seizures, or dangerously high temperature.^[7][1][5]

Call 911 for symptoms such as:

• Chest pain
• A seizure
• Psychosis, such as hallucinations or severe paranoia
• A very high body temperature
• Unresponsiveness or abnormally slow or stopped breathing when opioid exposure is possible.^[5][4][8]

Do not assume unusual behavior is “just the drug.” A positive stimulant test does not exclude another emergency, such as a serious condition affecting the heart, blood vessels, brain or nerves.^[5]

Stimulant-Related Psychosis and Mental Health

Stimulant-related psychosis can involve hallucinations and paranoia. Methamphetamine-related psychosis can resemble schizophrenia in some symptoms, and mood disorders commonly occur among people with methamphetamine use disorder.^[4]

This does not prove that stimulant exposure explains every psychiatric symptom. Genetics, trauma, family history, isolation, and pre-existing illness may contribute to both substance-use and psychiatric conditions.^[4]

Persistent symptoms after intoxication or withdrawal deserve a separate mental health assessment. Co-occurring conditions should not be ignored simply because stimulant use is present.

Stimulant-Related Heart and Organ Harm

Stimulant complications can affect the heart and blood vessels, lungs, brain and nerves, and kidneys. Possible injury mechanisms include reduced blood flow, excessive nervous-system stimulation, and direct toxicity.^[4]

In overdose surveillance, a known cardiovascular disease history was recorded in 38.7% of people whose stimulant-involved deaths did not involve opioids, compared with 21.2% of those whose deaths involved both stimulants and opioids.^[7] These figures describe people who died and should not be used to estimate risk for all stimulant users.

Unpredictable Illicit Stimulants and Counterfeit Pills

Illicit products may differ from one purchase or pill to the next. Synthetic cathinones can vary markedly in dose, onset, and duration, and many have uncertain pharmacokinetics, how the body absorbs, distributes, and removes a drug.^[4]

Counterfeit pills made to resemble ADHD or other prescription medicines may contain illicit fentanyl. Appearance, taste, and smell cannot establish whether fentanyl is present.^[8]

Fentanyl test strips can identify fentanyl in a tested sample, but a negative result cannot guarantee that the full product is fentanyl-free. The tested portion may not contain fentanyl, and some fentanyl-like substances may not be detected.^[8]

Recent overdose surveillance found that drug-checking programs rarely detected opioids in stimulant products, suggesting that many deaths involving both drug classes followed intentional co-use of separate products. Hidden exposure remains possible, particularly with counterfeit pills and an unpredictable illicit supply.^[7][8]

Treatment and Recovery from Stimulant Use Disorder

Stimulant use disorder is treatable, but no single approach works for everyone. Care may combine behavioral treatment, medical and psychiatric care, practical support, and treatment for other substance use disorders.

Contingency Management for Stimulant Use Disorder

Contingency management provides tangible, structured reinforcement for recovery-related behaviors. The American Society of Addiction Medicine (ASAM) and American Academy of Addiction Psychiatry (AAAP) guideline identifies it as the current standard of care for stimulant use disorder.^[5]

A Cochrane review of psychosocial treatments (psychological and behavioral approaches) included 64 randomized trials with 8,241 adults.^[16] Most studies involved cocaine or crack cocaine use disorder; fewer focused specifically on methamphetamine or amphetamine use disorder, so findings are not equally certain for every stimulant.^[16]

Compared with no psychosocial intervention, psychosocial treatment reduced treatment dropout by about 18% relative to the comparison group.^[16] It also probably increased continuous abstinence, meaning not using throughout a defined period, at the end of treatment, reduced how often people used stimulants, and lengthened their longest period of abstinence.^[16]

That 18% is a relative reduction, not 18 fewer dropouts per 100 participants.^[16] The absolute benefit depends on the comparison group’s dropout rate.^[16]

The evidence did not show a clear improvement in the proportion abstinent at a single end-of-treatment check or at the longest follow-up. This is not evidence that treatments are equivalent; it means superiority over no psychosocial intervention was not demonstrated for those outcomes.^[16]

The comparison matters. Against treatment as usual (care participants would otherwise receive) psychosocial treatment also reduced dropout, but showed less clear benefit for stimulant-use outcomes. In the no-intervention comparison, some trials added psychosocial treatment to usual care and compared that combination with usual care alone.^[16]

Contingency management was the most studied and promising approach in the Cochrane review.^[16] Its effectiveness can be limited when a person has no current intention to change, and availability has historically been uneven outside research and selected public systems.^[4]

Cognitive Behavioral Therapy and Other Stimulant Treatments

Cognitive behavioral therapy (CBT) helps people examine unhelpful thought patterns and practice coping skills for situations where substance use is more likely.^[5] Motivational interviewing helps people explore their own reasons for change and work through mixed feelings about changing, in a supportive conversation.^[17] Both were among the approaches studied in the Cochrane review; fewer studies examined them than contingency management.^[16]

These and other psychosocial approaches may help with engagement and stimulant reduction. However, the Cochrane review found fewer studies of approaches other than contingency management, making their estimates less precise.^[16]

Treatment retention matters even when abstinence is not immediate. For people not yet able to stop stimulant use completely, staying in treatment may help reduce risks associated with use.^[16]

Medication Evidence for Stimulant Use Disorder

No medication is approved by the U.S. Food and Drug Administration specifically for cocaine or methamphetamine use disorder, and there is no approved stimulant-overdose reversal agent.^[7][4]

“Off-label” treatment means using an approved medicine for a condition not listed in its regulatory approval. It can be considered when evidence and individual circumstances support it, but it is not the same as having an approved stimulant-use-disorder medication.

Clinical research has found signals of benefit for different medications in different disorders.

These should not be treated as interchangeable:

• For cocaine use disorder, evidence has supported consideration of stimulant-like agonist medicines (drugs that stimulate related chemical signaling) and a combination of extended-release mixed amphetamine salts with topiramate. Extended-release formulations release medicine over time.^[4]
• A meta-analysis cited by the ASAM and AAAP guideline found a small amount of evidence that bupropion improved sustained cocaine abstinence over placebo, with mixed findings among individual studies.^[5]
• For methamphetamine use disorder, outpatient research has reported signals for mirtazapine and for extended-release naltrexone combined with high-dose bupropion.^[4]

Medication findings concern particular populations, formulations and treatment settings. Decisions about these off-label options require clinical assessment, including other health conditions and substance use.^[5]

A review concluded that medication may serve as one part of outpatient care, but a single approach is unlikely to meet every need. Combining medication when appropriate with contingency management, cognitive behavioral therapy, and social or peer support may offer a broader recovery plan.^[4]

Next Steps for Stimulant Use Concerns

The right next step depends on whether the concern is an emergency, prescribed treatment, occasional nonmedical use, or a pattern of impaired control and harm.

If Someone May Be Having a Stimulant Overdose

Call 911 for suspected stimulant toxicity, especially with chest pain, seizure, dangerously high temperature, or psychosis such as hallucinations or severe paranoia.^[5][4]

Stay with the person if it is safe to do so. Emergency clinicians may still need to treat agitation, seizures, overheating, cardiovascular complications, or other stimulant effects after an opioid reversal medicine is given.^[7]

If You Are Concerned About a Stimulant Prescription

Do not judge the situation from one symptom or one difficult day. Write down the intended benefit, changes noticed, unwanted effects, sleep pattern, and questions for the prescribing clinician.

Bring a list of other medicines, supplements, caffeine products and substances you use. Ask your prescribing clinician or pharmacist, “Could any of these interact with my stimulant?” MedlinePlus specifically advises checking for caffeine interactions with medicines, including stimulants. Interaction questions are therefore relevant to prescribed care, not only to opioids or illicit products.^[2]

Seek prompt medical advice for new chest symptoms, severe mood changes, paranoia, hallucinations, or major sleep disruption. Do not use another person’s prescription or obtain pills from an unverified seller; counterfeit pills may closely resemble legitimate ADHD medicines and may contain fentanyl.^[8]

If Stimulant Use Is Becoming Hard to Control

A manageable first step is to describe the pattern honestly to a primary care, mental health, or substance-use professional. You can also explore treatment options. Useful details include the substance, frequency, amount, route, co-use, sleep, mood, cardiovascular symptoms, previous attempts to reduce use, and effects on daily life.^[5]

Ask specifically whether contingency management is available and whether the program addresses co-occurring mental health conditions or other substance use. If medication is discussed, ask what evidence applies to the particular stimulant involved and whether the proposed use is off-label.

If You Are Supporting Someone Who Uses Stimulants

Focus on observable concerns rather than labels. For example, describe missed responsibilities, prolonged sleeplessness, chest symptoms, paranoia, unsafe driving, unexplained pills, or repeated unsuccessful efforts to cut back.

Offer one concrete form of help, such as sitting with the person while they call a treatment service or helping arrange transportation. If they are not ready to stop, keeping communication open and discussing immediate risks may still be valuable.

Finding Help When Stimulant Treatment Is Hard to Access

The Substance Abuse and Mental Health Services Administration offers a confidential treatment resource for people in the United States and its territories. Its National Helpline provides free, confidential treatment information and referral at 1-800-662-HELP (4357), 24 hours a day.^[15]

For emotional crisis or suicidal thoughts, call or text 988 for 24-hour crisis support. Recovery may involve setbacks, changes in goals, and more than one kind of support, but continued engagement can still reduce risk and create opportunities for meaningful improvement.^[15][16]